Empresas Hites S.A. (SNSE:HITES)

Aerovate Therapeutics Ratios and Metrics

Market cap in millions CLP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	66,782	23,461	30,162	32,237	68,490	38,218
Market Cap Growth	-13.74%	-22.22%	-6.43%	-52.93%	79.21%	-53.51%
Enterprise Value	272,407	224,999	236,535	251,786	264,249	228,848
Last Close Price	99.90	59.31	76.25	75.72	131.03	73.12
PE Ratio	-	-	-	3.63	1.64	-
Forward PE	-	3.60	3.60	3.60	3.60	3.60
PS Ratio	0.21	0.07	0.09	0.09	0.17	0.13
PB Ratio	0.79	0.27	0.25	0.22	0.47	0.33
P/TBV Ratio	0.84	0.29	0.27	0.23	0.49	0.35
P/FCF Ratio	1.90	0.51	0.47	0.58	1.64	0.46
P/OCF Ratio	1.81	0.49	0.46	0.53	1.44	0.43
EV/Sales Ratio	0.86	0.71	0.73	0.68	0.65	0.79
EV/EBITDA Ratio	32.02	-	-	9.13	4.11	31.57
EV/EBIT Ratio	-	-	-	11.92	4.55	-
EV/FCF Ratio	7.74	4.88	3.68	4.51	6.32	2.73
Debt / Equity Ratio	2.59	2.38	1.86	1.63	1.62	2.17
Debt / EBITDA Ratio	25.86	99.65	-	6.08	3.20	16.87
Debt / FCF Ratio	6.25	4.48	3.48	4.35	5.67	3.03
Asset Turnover	0.86	0.84	0.76	0.82	0.92	0.67
Inventory Turnover	3.84	4.43	3.76	3.13	3.90	4.74
Quick Ratio	1.20	1.28	0.87	1.53	1.37	1.62
Current Ratio	1.85	1.78	1.22	2.22	2.17	2.13
Return on Equity (ROE)	-27.54%	-33.23%	-21.61%	6.01%	31.71%	-10.66%
Return on Assets (ROA)	-1.92%	-3.14%	-3.46%	2.92%	8.28%	-0.30%
Return on Capital (ROIC)	-2.24%	-3.76%	-4.00%	3.40%	9.63%	-0.35%
Return on Capital Employed (ROCE)	-	-	-	6.10%	17.10%	-
Earnings Yield	-40.58%	-146.73%	-96.67%	27.52%	60.87%	-34.44%
FCF Yield	52.69%	196.54%	213.21%	173.24%	61.00%	219.18%
Dividend Yield	-	-	-	9.32%	25.31%	-
Payout Ratio	-	-	-	140.99%	-	-
Total Shareholder Return	-	-	-	9.32%	25.31%	-

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.